Although it is unclear whether DPP-4 inhibitors are directly involved in the regression of HCC, the marked invasion of CD8+ T-cells was seen around the HCC tissue, suggesting that the DPP-4 inhibitors may improve the immune response [39]. This evidence concerns the gene CD8A and hepatocellular carcinoma.